Abingworth LLP 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-04-08 4:35 pm Purchase | 2022-03-29 | 13D | Soleno Therapeutics, Inc. SLNO | Abingworth LLP | 1,224,558 15.300% | 521,598 (+74.20%) | Filing |
| 2020-07-06 4:00 pm Purchase | 2020-06-26 | 13D | Soleno Therapeutics, Inc. SLNO | Abingworth LLP | 702,960 13.200% | 376,055 (+115.04%) | Filing |